Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer

Author：                      

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.3, Iss.1, 2012-01, pp. : 163-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Triple-negative breast cancer: molecular characterization and targeted therapies

By Nicholson Allen   Bishop Jennifer   Lannin Donald   Killelea Brigid   Guo Xiaojia   Cha Charles   Dixon J Michael  

Breast Cancer Management, Vol. 2, Iss. 5, 2013-09 ,pp. : 417-430

Future Medicine

Access to resources Recommend Favorite

Novel therapy for locally advanced triple-negative breast cancer

By                      

International Journal of Oncology, Vol. 47, Iss. 4, 2015-01 ,pp. : 1266-1272

Spandidos Publications

Access to resources Recommend Favorite

Clinicopathological features and treatment strategy for triple-negative breast cancer

By Yamamoto Yutaka   Iwase Hirotaka  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 341-351

Springer Publishing Company

Access to resources Recommend Favorite

Platinum-based therapy for triple-negative breast cancer treatment: A meta-analysis

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 720-724

Science Publishers

Access to resources Recommend Favorite

Imaging findings of triple-negative breast cancer

By Kawashima Hiroko  

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 145-145

Springer Publishing Company

Access to resources Recommend Favorite